(Q57543845)

English

Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: Sparfloxacin versus clarithromycin

scientific article published on 01 June 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Benjamin A. Lipsky

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

author name string

J Unowsky

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

H Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

L Townsend

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

G H Talbot

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 June 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

954-965

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Acute exacerbations of chronic bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acute exacerbations of chronic bronchitis: state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology and Treatment of Chronic Bronchitis and Its Exacerbations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic interactions related to the chemical structures of fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the treatment of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of infection in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro activity of sparfloxacin in comparison with currently available antimicrobials against respiratory tract pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980017-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(99)80017-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440620%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57543845&oldid=2173365758"